Oscar Health (OSCR) Short-term Investments (2020 - 2026)

Oscar Health has reported Short-term Investments for 7 years, with the latest figure at $2.0 billion in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments rose 165.43% year-over-year to $2.0 billion; the trailing twelve-month figure through Mar 2026 stood at $2.0 billion (up 165.43% YoY), and the FY2025 full-year result was $1.2 billion, up 94.8% from the prior year.
• Short-term Investments for Q1 2026 stood at $2.0 billion, up from $1.2 billion in the prior quarter.
• The five-year high for Short-term Investments was $2.0 billion in Q1 2026, with the low at $363.6 million in Q2 2024.
• Historically, Short-term Investments has averaged $943.8 million across 5 years, with a median of $887.6 million in 2025.
• Annual changes were most pronounced in 2024 — Short-term Investments sank 71.04% — and 2026, when it surged 165.43%.
• Oscar Health's Short-term Investments stood at $1.4 billion in 2022, then tumbled by 50.63% to $689.8 million in 2023, then dropped by 9.48% to $624.5 million in 2024, then soared by 94.8% to $1.2 billion in 2025, then soared by 63.97% to $2.0 billion in 2026.
• The last three Short-term Investments figures came in at $2.0 billion (Q1 2026), $1.2 billion (Q4 2025), and $887.6 million (Q3 2025), per Business Quant data.